Acer Therapeutics Inc.
ACERDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001069308
Acer Therapeutics Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Nov 20, 2023; 30 institutions reported holding it in 13F filings for Q3 2023, worth $3.40M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Acer Therapeutics Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −5 vs. Q2 2021
- Shares held
- 1.53M
- −36.9K (−2.4%) vs. Q2 2021
- Total value
- $3.91M
- −$562.1K (−12.6%) vs. Q2 2021
- New holders
- 2
- 5 more added
- Sold out
- 7
- 6 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACER on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $1.00K |
| Q3 2023 | 30 | $3.40M |
| Q2 2023 | 27 | $2.32M |
| Q1 2023 | 26 | $3.48M |
| Q4 2022 | 32 | $6.14M |
| Q3 2022 | 28 | $2.22M |
| Q2 2022 | 28 | $1.96M |
| Q1 2022 | 21 | $4.12M |
| Q4 2021 | 24 | $3.35M |
| Q3 2021 | 25 | $3.91M |
| Q2 2021 | 30 | $4.47M |
| Q1 2021 | 30 | $5.15M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Acer Therapeutics Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 48 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 58 | $0 | 0.00% | +14+31.8% | Added |
| JFS Wealth Advisors, LLC | 24 | $0 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1 | $0 | 0.00% | +1 | New |
| BNP Paribas Arbitrage, SA | 179 | $456 | 0.00% | 00.0% | Unchanged |
| O'Shaughnessy Asset Management, LLC | 225 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| Burleson & Company, LLC | 365 | $1.00K | 0.00% | 00.0% | Unchanged |
| Larson Financial Group LLC | 922 | $2.00K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 1,900 | $5.00K | 0.00% | +200+11.8% | Added |
| UBS Group AG | 5,176 | $13.0K | 0.00% | +2,907+128.1% | Added |
| Simplex Trading, LLC | 9,591 | $27.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 11,133 | $29.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 12,200 | $31.0K | 0.00% | −6,821−35.9% | Reduced |
| Parametric Portfolio Associates LLC | 13,488 | $35.0K | 0.00% | −646−4.6% | Reduced |
| Raymond James & Associates | 16,200 | $41.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 16,660 | $43.0K | 0.00% | −3,012−15.3% | Reduced |
| XTX Topco Ltd | 18,002 | $46.0K | 0.02% | −768−4.1% | Reduced |
| State Street Corp | 24,965 | $64.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 36,681 | $94.0K | 0.00% | +36,681 | New |
| Geode Capital Management, LLC | 64,024 | $163.0K | 0.00% | +6,415+11.1% | Added |
| Goldman Sachs Group Inc | 95,342 | $244.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 103,604 | $265.0K | 0.00% | −564−0.5% | Reduced |
| Vanguard Group Inc | 181,740 | $465.0K | 0.00% | +2,597+1.4% | Added |
| Nantahala Capital Management, LLC | 914,197 | $2.34M | 0.14% | −20,558−2.2% | Reduced |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −24,000−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −14,665−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −11,451−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,102−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −52−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −100−100.0% | Sold out |